06.08.2013
- Adaptation and Growth - For years, pharmaceutical companies have turned to emerging markets as low cost manufacturing destinations, utilizing lower wages and, frequently, less...
02.08.2013
- British drugmaker AstraZeneca warned on Thursday of higher costs in 2013 as it invests through a slump in sales caused by a wave of patent expiries on key medicines. The prediction...
01.08.2013
- U.S. chemical and seed company DuPont said on Wednesday it completed its three-year effort to buy a majority stake in South Africa's largest seed company, overcoming that country's...
30.07.2013
- U.S. government investigators said on Monday they still have few answers as to how an unapproved genetically altered wheat developed by Monsanto was found this spring growing in an...
30.07.2013
- Pfizer, in what could be the prelude to spinning off its generics drug business, said it plans to separate its commercial operations into two units, mainly for patent-protected...
24.07.2013
- Pioneering the Worldwide Health-Care Market - After years of showing low productivity, research and development in leading pharmaceutical and biotech companies is starting to...
22.07.2013
- Vivus has agreed to give dissident shareholder First Manhattan a board majority, ending an acrimonious proxy fight and bringing in a new CEO to the drugmaker accused of bungling...
18.07.2013
- The U.S. Supreme Court ruled on Monday that an Indiana farmer violated agribusiness company Monsanto's patent for a type of soybean. In a case closely watched by the biotechnology...
18.07.2013
- Monsanto said on Wednesday it will withdraw all pending approval requests to grow new types of genetically modified crops in the European Union, due to the lack of commercial...
18.07.2013
- Obesity drug maker Vivus, embroiled in a bitter proxy war with its top shareholder First Manhattan, said on Wednesday that FMC had rejected an offer to give the sides equal...
